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Abstract
Recent advances in the in vitro characterization of human adult enteric neural progenitor cells have opened new
possibilities for cell-based therapies in gastrointestinal motility disorders. However, whether these cells are able to integrate
within an in vivo gut environment is still unclear. In this study, we transplanted neural progenitor-containing neurosphere-
like bodies (NLBs) in a mouse model of hypoganglionosis and analyzed cellular integration of NLB-derived cell types and
functional improvement. NLBs were propagated from postnatal and adult human gut tissues. Cells were characterized by
immunohistochemistry, quantitative PCR and subtelomere fluorescence in situ hybridization (FISH). For in vivo evaluation,
the plexus of murine colon was damaged by the application of cationic surfactant benzalkonium chloride which was
followed by the transplantation of NLBs in a fibrin matrix. After 4 weeks, grafted human cells were visualized by combined in
situ hybridization (Alu) and immunohistochemistry (PGP9.5, GFAP, SMA). In addition, we determined nitric oxide synthase
(NOS)-positive neurons and measured hypertrophic effects in the ENS and musculature. Contractility of treated guts was
assessed in organ bath after electrical field stimulation. NLBs could be reproducibly generated without any signs of
chromosomal alterations using subtelomere FISH. NLB-derived cells integrated within the host tissue and showed expected
differentiated phenotypes i.e. enteric neurons, glia and smooth muscle-like cells following in vivo transplantation. Our data
suggest biological effects of the transplanted NLB cells on tissue contractility, although robust statistical results could not be
obtained due to the small sample size. Further, it is unclear, which of the NLB cell types including neural progenitors have
direct restoring effects or, alternatively may act via ‘bystander’ mechanisms in vivo. Our findings provide further evidence
that NLB transplantation can be considered as feasible tool to improve ENS function in a variety of gastrointestinal
disorders.
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Introduction
The Enteric Nervous System (ENS) poses the largest and
probably most complex division of the autonomic nervous system
and mainly controls the principal activities of the gut including
motility and secretion. Because of its important physiological role,
disturbances of the ENS can lead to severe symptoms that,
depending on the gut region, include dysphagia, gastro-esophageal
reflux, delayed emptying of the stomach, abdominal pain and
bloating, diarrhea, constipation, and fecal incontinence [1].
Symptoms are manifested in various diseases such as Hirsch-
sprung’s disease (HSCR), achalasia, gastroparesis or chronic
intestinal pseudo-obstruction [1,2]. Although there has been much
progress in diagnosis and therapy of these diseases, curative
treatment options are still limited and the long-term outcome often
remains unsatisfactory.
Multipotent neural stem and progenitor cells of the ENS have
been identified as a promising cell source for the treatment of at
least some ENS disorders, which may involve replacing or
restoring neural components or, alternatively, stimulating endog-
enous regenerative response [3–11]. Recently, in vitro protocols
have been developed which describe the propagation of mamma-
lian neural stem and progenitor cells, mainly as neurosphere-like
bodies (NLBs). These cells are capable of colonizing intestinal
tissue and differentiating into neural subtypes demonstrated mostly
ex vivo in organotypic tissue cultures [5,8,12]. There are few studies
in which the biological potential of these cells have been evaluated
in vivo. However, these studies were restricted to fetal or neonatal
cell sources and often without proof of functional effects in vivo
[13–17].
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In this study, for the first time we determined the in vivo
potential of human postnatal and adult ENS progenitors to
functionally integrate into murine host tissue with disturbed ENS
integrity. To induce damage of the ENS, we adapted a chemical
treatment protocol using benzalkonium chloride (BAC), which was
demonstrated to ablate the plexus of rodent colon tissue,
dependent to the concentration and time of exposure [13,18,19].
Human enteric NLBs were transplanted into BAC-treated gut
segments and tissue was analyzed histologically and functionally 4
weeks post-transplantation. Afterwards, within the gut wall, we
could detect differentiated neurons, glial and smooth muscle-like
cells derived from transplanted human cells. Although the total
number of ENS cells was not significantly different, functional
improvements in gut contractility were examined in organ bath
studies. Therefore, our study provides first evidence that NLB
transplantation is feasible to restore the motility function of guts
with disturbed ENS integrity.
Materials and Methods
Ethics Statement
Full-thickness gut samples were obtained from patients under-
going gut resection surgery due to various diagnoses (Table 1). The
study protocol was approved by the Ethical Committee of the
Medical Faculty, University of Leipzig, Germany and written
informed consent was obtained from the individuals to use ‘left-
over’ parts of the resected biological material for research purposes
(study approval number, Az. 066/2002). The data were analyzed
anonymously and according to the principles expressed in the
‘Declaration of Helsinki’.
The experimental animal in vivo protocols were approved by the
Ethics Committee of the State Directorate Leipzig, Germany
(study approval number, Az. 24-9168.11), and are in line with
international guidelines for animal welfare.
Generation and Culturing of Postnatal Enteric Progenitor
Cells
Enteric human progenitor cells were isolated and cultured as
described before [20]. Briefly, gut muscle strips were mechanically
dissected and enzymaticaly digested using a collagenase/dispase
enzyme solution (collagenase XI [750 U/mL; Sigma, Frickenhau-
sen, Germany] and dispase II [250 mg/mL; Roche, Mannheim,
Germany] in Hank’s balanced salt solution) for approximately 1
hour at 37uC under continuous rotating. Following trituration, the
cell suspension was filtered through a 70 mm cell strainer and
washed twice in Hank’s buffer. Cell pellet was resuspended in
Dulbecco’s modified Eagle medium (DMEM)/F-12 medium
(PAA, Coelbe, Germany) supplemented with penicillin (100 U/
mL; PAA), streptomycin (100 mg/mL; PAA), L-glutamine
(2 mmol/L; PAA), N2 (1:100; Invitrogen, Karlsruhe, Germany),
basic fibroblast growth factor (20 ng/mL; Peprotech, Hamburg,
Germany), and epidermal growth factor (20 ng/mL; Peprotech).
In all experiments, cells were initially seeded onto plastic dishes
coated with fibronectin, ornithin and laminin (2 mg/cm2; Sigma).
50% of medium was supplemented with conditioned medium
obtained from fast growing human fetal ENS (gut tissue obtained
after elective pregnancy terminations) in vitro cell cultures. Every
2–3 days half of the medium was replaced with freshly prepared
and conditioned medium. Cells were kept in culture for up to 21
days in a humidified incubator at 37uC, 5% CO2 and 2% O2
concentration. To induce cell differentiation, growth factors and
conditioned medium were omitted from culture medium and 2%
fetal calf serum and 200 mmol/L ascorbate-2-phosphate (Sigma)
were added. The analysis of photographed NLBs and gut sections
was estimated with ImageJ software (v1.38; National Institutes of
Health, Bethesda, USA.).
RNA Isolation and Quantitative PCR Analysis
Ribonucleic acid (RNA) isolation and quantitative polymerase
chain reaction (qPCR) procedure was performed as described
earlier [21]. Briefly, total RNA was isolated using an RNA Mini
Kit and genomic desoxy-ribonucleic acid (gDNA) eliminator
columns (Qiagen, Hilden, Germany). Purified RNA samples
underwent reverse transcriptase reaction according to the suppli-
er’s protocol (Superscript VILO cDNA Synthesis Kit; Invitrogen).
Quantitative real-time PCR was performed in the ABI Prism 7500
Real Time PCR System (Applied Biosystems, Darmstadt,
Germany) using the QuantiTect SYBR Green kit (Qiagen) and
the following primer sets (forward/reverse primer; all from
Invitrogen): p75 neurotrophin receptor [GenBank:
NM_002507.3], a molecular marker expressed in enteric neural
cells including stem and progenitor cells, (TGAGTGCTG-
CAAAGCCTGCAA/TCTCATCCTGGTAGTAG-CCGT;
230 bp), receptor tyrosine kinase (Ret) [GenBank: NM_020975.4],
a neuronal marker including neural progenitors, (AGATTTCG-
GATTTCGGCTTGT/CCACAGC-AGGACACCAAAAGA;
161 bp), tropomyosin alpha [GenBank: NM_001018005.1], a
smooth muscle cell marker, (TPM1; CTCGCAGAAGGAAGA-
CAGATATGAG/TAGT-TACTGACCTCTCCGCAAACTC;
101 bp) and the housekeeping gene hypoxanthine phosphoribo-
syltransferase 1 (HPRT1) [GenBank: NM_000194.2]
(TGAACGTCTTG-CTCGAGATGTG/CCAGCAGGTCAG-
CAAAGAATTT; 101 bp) to normalize gene expression data.
Relative gene expression was determined with the 2(-Delta Delta
C(T)) method. The quality of amplified PCR product was proved
by melting curve analysis and agarose gel electrophoresis to
estimate the size of each PCR product.
Fluorescence in situ Hybridization and Cytogenetics
Genomic alterations of human enteric progenitors were
evaluated by DNA fluorescence in situ hybridization (FISH) as
described recently [22]. Briefly, after preparation of cell meta-
phases and interphases, cells were denatured, dehydrated and
hybridized with multi-colour DNA FISH probe mixtures for 12–
16 h at 37uC (ToTelVysionTM, Abbott, Wiesbaden, Germany).
These probes bind to the sensitive subtelomeric chromosomal
regions which are immediately adjacent to the long (TTAGGG)n
repeats and also contain repetitive stretches of DNA (Figure 1I).
After washing, slides were air-dried for 20 min in the dark,
incubated with 49-6-Diamidino-2-phenylindole (DAPI) solution
(125 mg/ml; Abbott, Wiesbaden, Germany) for 10 min at room
temperature and coverslipped with Kaiser’s gelatine (Merck,
Darmstadt, Germany).
DNA in situ Hybridization
In situ hybridization (ISH) experiments were performed on 4%
phosphate-buffered paraformaldehyde (PFA, PAA) fixed cryosec-
tions using a digoxigenin-labeled, 224–base pair antisense DNA
probe corresponding to the consensus sequence of the human Alu
sequence [23]. The ISH staining protocol was performed as
described previously [20]. Color development was performed with
Nuclear Fast Red salt substrate solution (Sigma) or nitro-blue
tetrazolium (NBT)/5-bromo-4-chloro-39-indolyphosphate (BCIP)
(Roche) as described by the supplier. Alu-positive cells were
counted microscopically (256objective) from 4 non-consecutive
longitudinal serial cryosections (,15 mm61.5 cm) of each animal
(n = 10).
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Immunohistochemistry
Immunostaining was performed on cryosections of gut segments
as described earlier [20]. Briefly, cryosections and NLBs were fixed
in 4% PFA, rinsed in phosphate-buffered saline (PBS) (PAA) and
blocked with blocking solution (PBS containing 0.3% Triton X-
100 and 10% donkey serum, PAA) for 30 min. The following
primary antibodies diluted in PBS with 0.1% Triton X-100 were
applied overnight at 4uC: rabbit anti-p75 neurotrophin receptor
Figure 1. Characterization of multipotent neural progenitors isolated from human adult gut. (A) Bright-field view of representative adult
enteric neurosphere-like bodies (NLBs) after 14 days in vitro. Free-floating NLBs could be observed with an estimated average number of 35 NLBs per
preparation and a sphere diameter of 71.6 mm. Different NLB phenotypes include round- (star, comparable to B), ellipsoid- (white arrow, comparable
to C) or irregular-shaped (black arrow, comparable to D) NLBs. (B–D) Depending to the individual NLB phenotype, different cellular compositions can
be derived as shown for the ENS marker gene p75 in immunocytochemistry. (E–G) Proliferative NLB cells also incorporated BrdU and expressed
previously described progenitor markers including Sox2 and Nestin. (H–J) After 2 weeks of differentiation NLBs built a monolayer composed of
neuronal (TuJ), glial (S100b) and smooth muscle-like cells (SMA). (K–M) Molecular cytogenetic FISH analyses revealed no chromosomal alterations as
representatively shown for three chromosomal interphase nuclei. (N) A schematic illustration of a chromosome is shown. In total, 15 different probe
sets recognizing 41 different unique subtelomeric repeats were applied. (O) Efficacy and cellular distribution of NLBs strongly depends to the
individual preparation, relying on age, amount and quality of tissue, as demonstrated by qPCR analysis for three representative marker genes: p75,
Ret and tropomyosin (TPM). Scale bars represent in (A) 100 mm, (B–G) 25 mm, (H–J) 50 mm.
doi:10.1371/journal.pone.0093605.g001
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(1:250; p75, Promega, Mannheim, Germany), rabbit anti-S100b
(1:600; Dako, Hamburg, Germany), rabbit anti-smooth muscle
actin (1:400; SMA, AMS Biotechnology, Wiesbaden; Germany),
rabbit anti-beta tubulin III (1:2000; TuJ, Hiss Diagnostics,
Freiburg, Germany), mouse anti-Nestin (1:200; Millipore, Schwal-
bach, Germany), goat anti-SRY (sex determining region Y)-box 2
(1:50, Sox2, Santa Cruz, Heidelberg, Germany), rabbit anti-glial
fibrillary acidic protein (1:600; GFAP, Dako, Hamburg, Germany)
and rabbit anti-ubiquitin thiolesterase PGP9.5 (1:500; PGP9.5,
Millipore). After washing with PBS, the secondary antibodies
donkey anti-rabbit IgG-Cy3, donkey anti-rabbit IgG-Alexa488,
donkey anti-goat IgG-Alexa488 and donkey anti-mouse IgG-
Alexa488 (1:500, Invitrogen) were applied for 30 min at room
temperature, additionally DAPI solution (1 mg/ml, Roth, Karls-
ruhe, Germany) in PBS with 0.1% Triton X-100 for 10 min and
slides cover-slipped with Kaiser’s gelatin (Merck, Darmstadt,
Germany). Image capturing was done on a Nikon inverted
microscope (Nikon, Duesseldorf, Germany). All figures were
assembled and annotated using Corel Draw (v11.633 software;
Unterschleissheim, Germany) and ImageJ (v1.38; National Insti-
tutes of Health, Bethesda, USA.). For quantification of PGP9.5-
staining, the area of fluorescent cells in the plexus myentericus
region were measured microscopically (256objective) from 4 non-
consecutive longitudinal serial cryosections (15 mm6,1–1.5 cm)
of each animal (n = 6–7). Muscle thickness was measured on each
microscopic field in the central position orthogonally from the
outer muscle to the submucosal linings indicated by the
characteristic nucleus stainings.
BrdU Labeling
Cell proliferation was visualized by bromodeoxyuridine (BrdU)
proliferation assay. BrdU (10 mmol/L) was added for 1 hour to the
culture medium of proliferating spheres. Detection of ethanol-
fixed BrdU-positive cells was carried out with the BrdU Detection
Kit I (Roche, Mannheim, Germany).
NADPH-diaphorase Staining
Nicotinamide adenine dinucleotide phosphate (NADPH)-di-
aphorase staining was performed as described earlier [24]. Briefly,
4% PFA fixed cryosections were incubated in the dark at 37uC for
30 min in a solution of 3 mL PBS, 1.5 mg NBT (Roche), 3 mg
bNADPH and 1.5 mL Triton X-100 (Sigma). Samples were
counterstained with Nuclear Fast Red solution (Vector Laborato-
ries, Burlingame, USA) for 20 min at room temperature and
cover-slipped using Kaiser’s gelatin. For analysis, Fast Red and
nitric oxide synthase (NOS)-positive cells in the plexus myentericus
region were counted microscopically (256objective) from 4 non-
consecutive longitudinal serial cryosections (15 mm6,1–1.5 cm)
of each animal (n = 5–7).
Mouse Model and Transplantation of Human Enteric
Progenitors in vivo
8–12 weeks old (weight: ,20–35 g) immunodeficient, female
CD1 nude mice (Crl:CD1-Foxn1nu, Code 086/homozygous;
Charles River, Sulzfeld, Germany) were used for transplantation
experiments. Animals were anesthetized with 1–2% isoflurane/
oxygen mixture (CP Pharma, Burgdorf, Germany), and the
caecum was exposed through a 1 cm midline incision (Figure 2).
Sterile cotton gauze soaked with 0.01% or 0.05% BAC in 0.9%
sodium chloride (NaCl) solution (Delta Select, Munich, Germany)
was wrapped around the proximal colon (length: ,1.5 cm)
whereas the rest of the tissue was protected with cotton gauze
soaked in 0.9% NaCl solution. A drop of BAC solution was
reapplied to the gauze every 2–3 minutes to prevent drying. After
20 minutes, the treated area and peritoneum were thoroughly
flushed with NaCl solution. Prior transplantation, in vitro propa-
gated NLBs were digested with accutase (PAA) for 5–10 minutes at
37uC (dissociation controlled microscopically), diluted in basal
medium without any growth supplements up to 10 ml and
centrifuged at 200 g. The pellet was then mechanically triturated
in 3 ml fresh basal medium, centrifuged again and resuspended in
13 ml of basal medium. A mixture of 6.5 ml pre-warmed fibrinogen
with 6.5 ml cell suspension in basal medium (,105 cells total) and
13 ml thrombin (Baxter, Munich, Germany) was equally applied
on the treated gut segments using standard 20 ml pipettes in two
consecutive steps. Control animals (i.e. BAC-treated only/negative
control) received fibrin plus basal medium without cells. After
solidification of the matrix (,30 seconds), guts were carefully
repositioned in vivo and the wound was sutured in two layers.
Retacillin antibiotic (MIBE, Brehna, Germany) was intramuscu-
larly injected directly after wound closure. A mixture of antibiotic
(Baytril, Bayer, Leverkusen, Germany), analgetic (Metamizol,
WDT, Garbsen, Germany) and glucose (Braun, Melsungen,
Gemany) was given in the drinking water for the following 3 days
according to the manufacturer’s recommendations. After 4 weeks
post-transplantation, animals were killed via carbon dioxide (CO2)
inhalation and cervical dislocation and resected tissues processed
for functional and histological analyses (Table 1). In total, ten
animals were transplanted with ten individual human donor cell
samples.
Electrical Field Stimulation and Isometric Muscle
Recording
Functional evaluation of colonic contraction was measured in
three experimental groups after four weeks post-transplantation:
untreated control, BAC-treated and BAC-treated/cell-transplant-
ed guts. Guts were carefully prepared, washed in Krebs buffer
(Sigma) and connected to a force transducer via a string in an
organ bath (TSE Systems, Bad Homburg, Germany). Tissue was
pre-contracted and maintained in Krebs buffer gassed with
carbogen (95% O2 und 5% CO2) at 37uC. Two control
stimulations were performed via 1 mM acetylcholine (ACh, Sigma)
at the beginning and end of each experiment. In between, two
electrical field stimulations (EFS) (250 mA, 8 Hz, 5 ms pulse for
30 seconds) and one stimulation with 1025 M tetrodotoxin were
applied (Biotrend, Cologne, Germany) to verify EFS-induced
nerval activation. Following equilibration and control contraction,
EFS-induced contraction was determined as percentage change
from baseline muscle tone relative to the maximum acetylcholine
contraction peak. For quantitative determination of EFS-induced
contraction, intestinal gut segments from at least 6 mice per group
were analyzed.
Statistical Analysis
All data are expressed as mean and standard deviation (SD).
Box-whisker plots show the 25th and 75th percentiles, the middle
line represents the median, and the whiskers extend to the lowest
and highest data points. Due to the limited and varying sample
sizes, statistical significance was determined by nonparametric
Kruskal-Wallis test and Fisher’s least significant difference (LSD)
error protection as suitable alternative to analysis of variance
(ANOVA) test. A P-value below 0.05 was considered to be
statistically significant, a P-value between 0.05 and 0.15 was
considered as moderate evidence for statistical significance with
biological relevance.
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Results
Characterization of Human Progenitors in vitro
With our experimental approach, we were able to reproducibly
generate proliferating neural progenitors as neurosphere-like
bodies (NLBs) from postnatal and adult human gut tissue. We
observed a relatively high variability in growth efficiency and
cellular composition dependent to age, amount and quality of gut
samples. NLBs generation efficiency tend to be higher from
younger donors compared to older donors considering same
biopsy size and cultivation duration. After 2–3 weeks of in vitro
culture, free-floating NLBs could be observed with an estimated
average number of 35 NLBs per donor and a sphere diameter of
71.2+–32.8 mm (Figure 1A, n= 11 analyzed patients aged between
0.5 and 95 years, mean age: 56.3+–30.5 years). The total cell
number counted from dissociated NLBs varied between 36104
and 2.26105 cells (mean: 96104+–76104 cells; n = 3). Expression
of the neurotrophin receptor p75, a molecular marker also
expressed in enteric neural progenitor cells, was found in 37.5+–
12.1% of all NLB cells (n = 4) as analyzed by immunohistochem-
istry (Figure 1B–D). Other previously described neural progenitor
markers were also present such as Sox2 or Nestin and cells
incorporated BrdU indicating active proliferation (Fig. 1 E–G).
The remaining non-neural cells stained for mesodermal markers
such as smooth muscle actin, for instance (data not shown). Under
differentiation conditions for 14 days NLBs rapidly built a
monolayer, which included neuronal, glial and smooth muscle-
like cells (Fig. 1H–J).
Interestingly, p75 was not homogenously expressed in the NLBs
and three main types of NLBs could be identified: (i) round-shaped
spheroids with compact appearance which uniformly expressed
p75 (Figure 1A, star and Figure 1B) (ii) ellipsoid-shaped spheroids,
probably generated by fusion of two smaller spheroids, mostly
expressed less than 100% of p75 (Figure 1A, white arrow and
Figure 1C) (iii) large irregular-shaped spheroids with darker
appearance (p75-negative), partly fused with small, compact p75-
positive stained cellular structures (Figure 1A, black arrow and
Figure 1D). NLB types significantly varied between individual
preparations, probably dependent to tissue integrity, which
ultimately resulted in variations of the mRNA gene expression
profile as shown for the three representative marker genes p75
(neural progenitors and differentiating cells), Ret (neuronal cells)
and tropomyosin (TPM, smooth muscle-like cells) (Figure 1O;
n= 9 analyzed patients aged between 2 month and 84 years, mean
age: 52.1+–34.5 years). Interestingly, the neuronal (progenitor)
marker gene Ret was significantly up-regulated (,10-fold) in
NLBs from older patients (60–84 years) compared to children (0–8
years), whereas no significant differences were observed with p75
or TPM (data not shown). Because p75 marks both, progenitors
and differentiating neural cells (i.e. neurons and glia), changes in
Ret expression suggests a relative increase in differentiated
neuronal phenotypes in cell cultures obtained from older donors.
To further characterize NLBs, we performed a subtelomere
FISH analysis to exclude DNA microdeletions or microduplica-
tions in the sensitive subtelomeric chromosomal regions
(Figure 1N). We applied 15 probe mixtures detecting 41 specific
subtelomere regions and found no indication of chromosomal
instability after analyzing 80 interphase nuclei (n = 3, patients aged
between 72 and 76 years) and according to the ‘International
System for Human Cytogenetic Nomenclature’ 2009 [25]. In
figure 1K–M, representative cell nuclei are shown demonstrating
an inconspicuous FISH staining pattern.
ENS Ablation and NLB Transplantation in vivo
To constitute a small colonic segment with disturbed ENS
function (i.e. hypoganglionosis), we applied the cationic surfactant
benzalkonium chloride (BAC) (Figure 2). Dependent to the
concentration and time of incubation, treatment with BAC has
been shown to lead to transient enteric plexus ablation (i.e.
hypoganglionosis) and hypertrophy as well as hypertrophy of the
musculature. We have tested 2 different concentrations of BAC
(0.01% and 0.05%) aiming to generate a moderate damage with
minimal animal suffering and good survival of the recipient mice.
The higher BAC concentration resulted in an already macroscop-
ically visible damage of the treated gut segment (e.g. damaged
vasculature) after 20 minutes of application (data not shown).
Consequently, approximately 90% of all treated animals (n = 24)
developed a severe intestinal obstruction and either died or were
killed within the first 5 days to shorten animal suffering. After gut
dissection, we noticed the constricted segments accompanied by
extremely distended proximal colon/caecum as well as small
intestine filled with abnormal amounts of condensed feces still
visible in the surviving animals 4 weeks following operation. In
contrast, 80% of animals (n = 28) treated with the lower BAC
concentration survived the 4 weeks follow-up phase without any
visible signs of suffering, weight-loss or macroscopically alterations
of gut integrity. On a microscopic level, however we could still
identify and quantify hypertrophic effects in the regenerating
plexus structures and smooth musculature (Figure 3A–D,
Figure 3F, G). In average, the mean size of ganglia, measured
via the PGP9.5+ area, significantly increased from 180 mm2
(control) to 294 and 389 mm2 (BAC-treated groups without and
with cells, respectively); 30–62 ganglia per animal were analyzed.
Figure 2. Experimental procedures of ENS ablation and cell transplantation. (A) Adult CD1 nude mice were anesthetized and the caecum
was exposed through a 1 cm midline incision. (B) Cotton gauze soaked with 0.01% benzalkoniumchloride (BAC) was wrapped around ,1.5 cm of
proximal colon whereas the rest of the tissue was protected with cotton gauze soaked in NaCl solution. (C) After ,20 min the BAC was thoroughly
flushed away with NaCl solution. (D) 26 ml of fibrin/cell matrix, equally mixed of fibrinogen/cells and thrombin solution, was applied on the treated
gut segment. (E) Guts were carefully placed back into the original in vivo position, the wound was sutured in two layers and finally sealed with
medical wound glue.
doi:10.1371/journal.pone.0093605.g002
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In contrast, the mean cell number per ganglion, determined by
Fast Red-positive cell number, was only moderately, but not
significantly decreased after BAC-treatment. Between 250–450
total Fast Red+ cells per animal, organized as densely-packed
ganglion structures, were counted. Interestingly, a relative
decrease of NOS-positive neurons (in % of Fast Red-positive
myenteric plexus cells), which represent the majority of plexus
cells, and neuronal fibers was detectable in the BAC-treated
animals (Figure 3B, E).
In order to evaluate the potential of NLB-derived cells to
participate or promote in vivo plexus regeneration, we transplanted
an average cell number of ,105 cells of unsorted neurosphere-
derived cultures in a clinically approved fibrin matrix onto the
complete serosal surface of the treated gut segments (Figure 2D).
Interestingly, compared to the BAC-only group, in the (immuno-
)histological analyses no statistically significant differences on both
the number of NOS-neurons as well as the hypertrophy of the
plexus (i.e. PGP9.5+ mean ganglia size) and smooth musculature
were observed (Figure 3E–G). Noteworthy, if considering only the
subgroup of older donors (.40 years), the hypertrophic effects
tend to be less pronounced compared to the younger donor group
suggesting age-dependent effects. Due to the small number of
patients, however this could not be statistically ensured.
Integration of Human NLBs in vivo
To clarify the transplanted cell fate i.e. whether and where the
transplanted human progenitors have been integrated within the
host tissue, we performed DNA in situ hybridization (ISH) using a
probe for the highly repetitive Alu sequence that specifically
detects human cell nuclei as proved in human and mouse control
tissues (Figure 4C, D). In our experiments, we detected Alu-
positive human cells in 8 of 10 transplanted animals, although with
high variability (Figure 4A, B, I; n = 10 animals ranging from 0 to
176 Alu+ cells/slice, mean: 35.2+–53.7 cells/slice). 5 of the 8
animals revealed relative high numbers of integrated human cells
(,20–180 cells/slice), although the estimated total number of
surviving cells in the treated gut segment is far less than the initial
transplanted cell number suggesting relatively moderate cell
survival and/or integration. Noteworthy, there seem to be slight
age-dependent effects of donors with respect to an increased extent
of cell integration; however, the number of analyzed patients was
too low to apply any robust statistics. Most of the human cells were
found within the longitudinal muscle (79%), the remaining cells in
the inner circular muscle region (21%). Interestingly, we also
discovered cells clustering in the known plexus region suggesting
either neo-ganglia formation or integration of transplanted neural
cells into existing/regenerating plexus structures (Figure 4A,
Figure 3. Alterations of the ENS four weeks post-operation. (A, B) Low-magnification bright-field view of NADPH-diaphorase staining
demonstrates a visible and relative reduction (i.e. hypoganglionosis) of neuronal cells (shown as %NOS+ of Fast Red+ myenteric plexus cells, dotted
lines) as well as neuronal fibers compared to untreated gut control tissues. Note that the musculature is thickened due to hypertrophic effects of BAC
as indicated by the white bar. Nuclei are stained red with Nuclear Fast Red dye. (C, D) Compared to the control, hypertrophic effects are also
detectable in the ENS as shown by immunohistochemistry for PGP9.5 (arrowheads). Nuclei were stained with DAPI (blue). (E) Quantification of NOS-
positive cells in the myenteric plexus, (F) mean ganglia size indicated by PGP9.5 cytoplasmatic immunostaining, and (G) muscle thickness. As seen in
box-whisker plots, damage of the ENS and muscle was still quantifiable four weeks after BAC-treatment, however in this analysis, no statistical
significant effects were seen by additional cell transplantation compared to the BAC-only treated group. (A–D) Scale bars represent 100 mm.
M=mucosa, CM= circular muscle, LM= longitudinal muscle. (E–G) *P,0.05 and 0.05, 1P,0.15 as compared to the untreated controls.
doi:10.1371/journal.pone.0093605.g003
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arrowhead). This observation could also be verified by co-
immunostaining with characteristic ENS differentiation markers,
such as PGP9.5 to identify neurons (Figure 4E, F) and GFAP for
glial cells (Figure 4G) indicating the presence and survival of
neural cells in vivo. However, the majority of cells were not found
within ganglia structures, but rather as single cells located in the
smooth muscle layers or in close contact to ganglia. Co-staining for
SMA verified the presence of non-neural phenotypes such as
smooth muscle-like cells (Figure 4H). Unfortunately, due to
technical reasons a quantification of double-stained human cells
was not applicable since all used antibodies, established for in situ
hybridization and immunohistochemistry, are cytoplasmic mark-
ers, and therefore not suitable for a precise allocation.
Analysis of Gut Contractility
According to our ISH results, there was the possibility that we
might able to detect beneficial effects of human cell transplantation
on a functional level. Therefore, we first demonstrated that BAC
could cause detrimental effects on gut contractility after the 4
weeks follow-up as a consequence of the ENS damage seen in
histology. Resected gut segments (Figure 5A–C) were placed into
an organ bath filled with physiological Krebs solution and
electrical field stimulations (EFS) was performed to assess neurally
mediated contractions of the smooth musculature. Acetycholine
(ACh)-induced contractions were included before and after EFS
and served as reference control (Figure 5E). For unknown reasons,
5 of 24 analyzed guts (26control, 16BAC, 26BAC +cells) showed
no reaction, neither to ACh nor to EFS, probably due to technical
problems and therefore could not be included in the analysis. In
the remaining guts, BAC-treatment caused a notable ,50%
inhibition of contractile response after EFS (Figure 5D; n= 7,
P= 0.06 vs. controls), although the variability of results was
relatively high, which resulted in a moderate statistical P-value. In
contrast, this inhibitory effects on contractility was reduced in the
transplantation group (Figure 5D; n= 6, P= 0.43 vs. controls),
which was even more distinct if only the younger donors were
considered. The functional data therefore suggest that NLB
transplantation indeed may have physiological effects, even if not
clearly reflected on a histological level.
Discussion
Several studies in mammals have confirmed the presence of
multipotent adult stem and progenitor cells in ENS in vitro and
in vivo. This was shown in age-dependent biomarker studies [26–
29], ENS ablation in vivo models [18,30,31] and numerous in vitro
ENS stem cell studies [4,17,28,32–34]. A more recent in vivo
approach in adult mice additionally specified enteric neurogenesis
taking place within stem cell niches between the myenteric plexus
and the longitudinal muscle layer [35]. In comparison to animal
studies first in vitro approaches could also successfully demonstrate
stem- and progenitor cells in human gut, mainly propagated as
NLBs [5,8,12]. NLBs were isolated from early postnatal full-
thickness gut samples and showed a heterogeneous expression of
ENS progenitor markers (Sox10, p75, Ki67) as well as mature
neuronal subtype markers especially after induction of differenti-
ation [36–38]. More recently, we established protocols for the
propagation of NLBs from human adult gut samples (aged up to
89 years), which could be differentiated into electrophysiological
active neurons in vitro [20]. In the present study, we modified the
existing protocols by adding conditioned medium from human
fetal cultures instead of murine fetal cultures and NLBs were kept
under hypoxic culture conditions (2% O2) instead of normoxic
conditions (,20% O2), which revealed further beneficial effects on
NLB expansion [21]. Our cytogenetic analysis (i.e. subtelomeric
FISH) revealed no detrimental effects of our culture protocol on
Figure 4. Integration of transplanted human NLBs in vivo. (A) Example of in situ hybridization (ISH) for human-specific Alu sequence with
good cell integration within the gut musculature. Note that ganglia-like structures can be detectedat the expected location between the circular and
longitudinal muscle layer (arrowhead). (B) Representative example for poor cell integration i.e. only a single cell was detected in this microscopic view
(arrowhead). (C) Alu-ISH on human control gut tissue demonstrates the specifity of Alu probe for human cells. (D) ISH with Alu probe on mouse tissue
served as negative control. Note, that there is some unspecific background staining in the cytoplasm and extracellular matrix, which does not co-
localize with Dapi+ nuclei (stars). (E) Alu-ISH was combined with immunohistochemistry (IHC) to demonstrate in vivo differentiation state of neuronal
cells between the longitudinal and circular muscle layers (Alu, black nuclei and PGP9.5, brown cytoplasmic staining). (F–H) Fluorescence ISH for Alu
combined with IHC in a higher magnification (Alu-ISH, red nuclei and IHC, green cytoplasma) (F) A PGP9.5/Alu co-stained human cell has been
integrated in a small ganglion structure (arrowhead). (G) Differentiated human glial cells within a ganglion as shown by Alu/GFAP-co-staining
(arrowheads). (H) Most of the transplanted cells (arrowheads) were found around ganglion structures (stars) in the smooth muscle layers as shown by
Alu/SMA-co-staining. (I) Variability of human cell integration was quantified and demonstrated as box-whisker plots. Most cells were found within the
longitudinal muscle layer. Scale bars in (A–D) 100 mm, (E) 50 mm, (F–H) 200 mm. M=mucosa, CM= circular muscle, LM= longitudinal muscle.
doi:10.1371/journal.pone.0093605.g004
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chromosomal stability. Analyzing chromosomal aberrations is an
important safety issue for future clinical applications of enteric
neural cell-based therapies. It is also worth noting that multipotent
human neural progenitors can principally be isolated from
mucosal biopsies, which represents a practical advance towards
the development of future cell-therapeutic approaches [39]. After
injection into aganglionic gut explant cultures, postnatal and adult
human progenitors have been shown to differentiate into neurons
and glia and could partly improve gut functionality in vitro [20,38].
Overall, these exciting progresses in the field of ENS stem cell
research have suggested alternative therapeutic, autologous cell-
based options in the treatment of gastrointestinal motility
disorders, knowing that the current are unsatisfactory and rather
palliative than curative [3,6,40,41]. However, a critical step for the
further translation of this concept into clinical studies would be
pre-clinical animal in vivo studies. There are few studies in which
ENS progenitors, isolated either from fetal or early postnatal
mammalian gut, have been transplanted in rodents leading to a
significant proportion of differentiated cells within the host tissue
[13–17]. Two of the studies also performed functional examina-
tions demonstrating recovery of intestinal motility [14,17].
In contrast to previous studies, for the first time we evaluated
the biological in vivo potential of human adult progenitors and
included functional analyses. The high variance observed in the
propagation of NLBs in vitro seems strongly dependent to the
quality, amount and age of the individual gut biopsy and has been
noticed before [28,32,39]. In addition, NLBs contained a relatively
heterogeneous mixture of progenitors, demonstrated by ,40%
p75-immunopositive cells and further differentiated cells (i.e.
neurons, glia, mesenchymal cell derivatives). This phenomenon
has also been described for NLBs from the central nervous system
before and poses a practical problem for standardized approaches
[42,43]. However, despite knowing the associated disadvantages of
NLBs, but in light of this first scientific proof-of-concept study, we
continued to use this well-established culture technology and only
considered the total cell numbers because (i) no standardized
protocols for pure human monolayer ENS stem cell cultures have
been established so far, (ii) no exclusive cell surface biomarkers
allowing to apply sorting techniques for human ENS progenitors
are available, (iii) NLB generation is the state-of-the-art technology
to generate a minimum ENS cell mass necessary to perform any
in vivo experiment, and (iv) NLBs represent an approximated in vivo
ENS niche which could thoroughly have beneficial effects for
survival and functional integration of transplanted cells. However,
there is no doubt that we have to further improve and standardize
the existing protocols for future studies that we can finally provide
acceptable protocols for clinical studies. This includes particularly
the development of efficient scale-up protocols in progenitor cell
culture and subsequent cell sorting strategies.
A second question also addressed in our study was to find a
feasible cell delivery method to the site of transplantation. The
in vivo studies mentioned above either injected cells locally into the
gut or via the intraperitoneal route. Both strategies certainly have
their advantages and were successful in the sense that cells, at least
in parts, survived and integrated into the host tissue. However, the
intramural, technically quite challenging injection method needs
to be done repeatedly to cover larger areas of denervated gut
segments and bears the obvious risk of life-threatening gut
perforation. Additionally, only small volumes of concentrated cell
suspensions can be injected at one time, which might be
Figure 5. Macroscopic evaluation and organ bath analysis of transplanted gut tissues. (A, B) Concentration-dependent severity of gut/
ENS damage after BAC-treatment is visible in resected gut tissues. Higher concentrations resulted in severe obstruction proximal to the treated gut
segments indicated by condensed feces and tissue dilatations (arrows) leading to death of the majority of animals within few days. Lower BAC-
concentrations instead led to a moderate damage of the gut tissue with good animal survival. (C) Segments treated with 0.01% BAC (black bar, with
and without cell transplantation) and control gut tissues (i.e. normal gut) were placed in the organ bath between two electrodes (star) for further
analysis of EFS-induced gut contractility. (D) Quantification of EFS-induced isometric contractility relative to the Acetylcholine (ACh)-induced control
contraction is shown in box-whisker plots. The tissue damage caused by BAC (1P= 0.06) could be partly abolished after cell transplantation (P = 0.43)
compared to control tissues. (E) Representative plots showing the ACh control peaks at the beginning and end of each measurement. After EFS
application, contractions were particularly diminished in the BAC-only treatment group, which could be partly restored after cell transplantation.
doi:10.1371/journal.pone.0093605.g005
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insufficient to cover larger areas (e.g. due to cell clumping and
limited spatial distribution). Intraperitoneal injection of cells is a
quick procedure and certainly may cover larger tissue areas,
however, in a rather unspecific way which eventually poses a
considerable safety risk in clinical applications. In addition, the
colon seems not be susceptible for this technique [15]. As an
alternative approach, we therefore tested a biodegradable fibrin
matrix which has been clinically approved for several years and is
available as sterile-packed and ready-to-use spraying device. With
this technique, we observed notable cell integration in 40% of all
transplanted animals, only 20% of all animal showed no cell
integration in histology. Besides the positive regulatory aspect, this
technique also combines scientific advantages of the other
mentioned delivery routes in the respect that it is a quick
procedure and covers large tissue areas at the same time.
Furthermore, important stimuli such as cell growth factors,
survival factors or immune-modulatory drugs could be addition-
ally immobilized in the matrix in future studies. Nevertheless, also
with this technique, cells still need to home from the matrix into
the gut tissue. This leads to remaining risks that parts of the matrix
are either sheared during re-positioning of the gut after surgery or
due to normal gut peristalsis and potentially settle into other target
tissues. To prove this, time-dependent in vivo tracking and safety
studies would be interesting and necessary.
In order to induce ENS dysfunction in vivo, we used the
chemical benzalkoniumchloride (BAC)-induced denervation mod-
el, which has been previously described in rodents [14,19,44,45].
In contrast to available genetic animal models (e.g. Sox102/2,
Ret2/2), this model allows the induction of dysfunctional
innervation in a well-defined segment of adult gut. In this respect,
it is interesting to note, that ENS donor cells prefer to migrate into
aneural gut segments than in tissues containing an intact ENS, as
shown in a previous study [46]. Due to transplantation of human
cells in this study, immunodeficient CD1 nude mice were used to
prevent immune rejection. The higher sensitivity to exogenous
influences, caused by the lack of thymus, prompted us to use a
relatively low BAC concentration (0.05%) which has been
published for Balb/c wildtype mice before [18]. However, we
experienced high animal mortality with this concentration, mainly
due to severe intestinal obstruction. In contrast, further reduction
to 0.01% BAC finally resulted in good animal survival with still
detectable damaging effects in histology (i.e. ENS hypoganglio-
nosis, neuronal and muscular hypertrophy) as well as organ bath
experiments (i.e. disturbed contractility) after 4 weeks follow-up.
Interestingly, whereas little or no differences in histology were seen
between the BAC-treated group and the BAC-treated/cell-
transplanted group, notable biological effects in the functional
evaluation were detected, although with moderate statistical P-
values due to the relatively low number of animals included in this
pilot study. However, our results suggest that the transplanted
NLB cells did indeed have notable biological effects on the
integrative neural activity either by replacing dead or dying ENS
cells or by acting as ‘bystander cells’ stimulating the intrinsic
regenerative response. In this respect, it is worth noting, that most
of the transplanted cells were outside of ganglia and negative for
pan-neural differentiation markers (PGP9.5, GFAP) supporting
mainly the ‘bystander theory’ and data from a recently published
in vivo study in rats [15]. Furthermore, there is a possibility that
these cells are still undifferentiated stem cells residing in the
germinal niches between the myenteric plexus and longitudinal
muscle in adult mice [35]. In future studies, it would be of great
interest to investigate this theory by doing cell fate mapping studies
beyond the 4 week time point. Furthermore, large-scale and large
animal studies will be necessary to confirm our first observations.
Nevertheless, a small, but critical number of cells seem to be
capable to restore parts of gut function which is promising
considering the clinical need for treatments of rather larger areas
of diseased gut tissue.
Conclusions
In conclusion, we could demonstrate the reproducible, serum-
free propagation of human adult enteric progenitors as NLBs with
no signs of chromosomal alterations using subtelomere FISH.
These NLBs, suspended in a clinical-approved fibrin matrix, were
able to integrate and survive following in vivo transplantation in
murine gut. Notable biological effects of transplanted cells on gut
contractility were observed in an immunodeficient mouse model
for hypoganglionosis. Thus, our pilot study provides the first in vivo
validation of human adult enteric NLBs in an animal model and
support the idea that these cells may be a promising, almost
unlimited source for novel cell-based therapeutics to cure patients
with gut motility disorders.
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